Dual Targeting of PI3Kγ and STING Overcomes Regulatory B Cell- and Myeloid Cell-Driven Immune Suppression in Pancreatic Cancer

Scientists discovered that STING agonist expanded regulatory B cells depended on PI3Kγ but not PI3Kδ in pancreatic cancer, whereas activating myeloid cells were independent of PI3Kγ.